U.S., Oct. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07220824) titled 'A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting' on Oct. 22.
Brief Summary: The purpose of this study is to assess how well guselkumab works in improving symptoms of psoriatic arthritis (an inflammatory disease that affects the joints in participants with psoriasis, a skin condition that causes red, scaly patches) using muscoloskeletal ultrasound (MSUS) in a real-world setting.
Study Start Date: Oct. 31
Study Type: OBSERVATIONAL
Condition:
Arthritis, Psoriatic
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Janssen Research & Development, LLC
Published by HT Digital Content Service...